CLINICAL TRIALS PROFILE FOR FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER

All Clinical Trials for FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00002850 ↗	Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy	Completed	Eastern Cooperative Oncology Group	Phase 3	1997-03-01	RATIONALE: Giving antibiotics may be effective in preventing or controlling early infection in patients with multiple myeloma and may improve their response to chemotherapy. PURPOSE: This randomized clinical trial is studying antibiotics to see how well they work compared to no antibiotics in preventing early infection in patients with multiple myeloma.
NCT00002850 ↗	Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy	Completed	National Cancer Institute (NCI)	Phase 3	1997-03-01	RATIONALE: Giving antibiotics may be effective in preventing or controlling early infection in patients with multiple myeloma and may improve their response to chemotherapy. PURPOSE: This randomized clinical trial is studying antibiotics to see how well they work compared to no antibiotics in preventing early infection in patients with multiple myeloma.
NCT00002850 ↗	Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy	Completed	Gary Morrow	Phase 3	1997-03-01	RATIONALE: Giving antibiotics may be effective in preventing or controlling early infection in patients with multiple myeloma and may improve their response to chemotherapy. PURPOSE: This randomized clinical trial is studying antibiotics to see how well they work compared to no antibiotics in preventing early infection in patients with multiple myeloma.
NCT00419380 ↗	Treatment of Clogged Tympanostomy Tubes: An Off-Label Use of Dornase Alfa (Pulmozyme®)	Completed	Genentech, Inc.	Phase 4	2007-01-01	The purpose of this study is to evaluate Pulmozyme® (dornase) as compared to a standard ear drop Floxin® (ofloxicin) to dissolve clogged tubes. This study will monitor the use of the new drug for any problems related to the medication. Patients are being asked to be in this study because they had tubes placed for the treatment of chronic ear infection and the tube(s) are now clogged. Clogged tubes are a common problem found in children with tubes. This problem occasionally is improved with ear drops like Floxin®. However, it is frequently not improved even after this standard ear drop treatment.

Clinical Trial Conditions for FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER

Condition Name

Condition Name for FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Intervention	Trials
Diabetic Foot Ulcers	2
Otitis Media	2
Acute Otitis Media	1
Glaucoma	1

Condition MeSH

Condition MeSH for FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Intervention	Trials
Otitis Media	3
Ulcer	2
Foot Ulcer	2
Diabetic Foot	2

Clinical Trial Locations for FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER

Trials by Country

Trials by Country for FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Location	Trials
United States	23
South Africa	1
Peru	1

Trials by US State

Trials by US State for FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Location	Trials
Washington	3
Oregon	2
New York	2
Colorado	1
Wisconsin	1

Clinical Trial Progress for FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER

Clinical Trial Phase

Clinical Trial Phase for FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	6

Clinical Trial Status

Clinical Trial Status for FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Clinical Trial Phase	Trials
Completed	6
Active, not recruiting	1
Enrolling by invitation	1

Clinical Trial Sponsors for FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER

Sponsor Name

Sponsor Name for FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Sponsor	Trials
MacroChem Corporation	2
Genaera Corporation	2
Abeona Therapeutics, Inc	2

Sponsor Type

Sponsor Type for FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Sponsor	Trials
Industry	10
Other	8
NIH	1